4-6923499-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020773.3(TBC1D14):c.110C>T(p.Ala37Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020773.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D14 | ENST00000409757.9 | c.110C>T | p.Ala37Val | missense_variant | 2/14 | 1 | NM_020773.3 | ENSP00000386921.4 | ||
TBC1D14 | ENST00000448507.5 | c.110C>T | p.Ala37Val | missense_variant | 2/14 | 5 | ENSP00000404041.1 | |||
TBC1D14 | ENST00000444368.1 | c.110C>T | p.Ala37Val | missense_variant | 2/2 | 3 | ENSP00000414951.1 | |||
TBC1D14 | ENST00000427736.1 | c.110C>T | p.Ala37Val | missense_variant | 2/2 | 2 | ENSP00000411760.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251438Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135904
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727242
GnomAD4 genome AF: 0.000164 AC: 25AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.110C>T (p.A37V) alteration is located in exon 2 (coding exon 1) of the TBC1D14 gene. This alteration results from a C to T substitution at nucleotide position 110, causing the alanine (A) at amino acid position 37 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at